Third Circuit Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 61 - 70 of 1,269
Allergan USA, Inc. et al v. MSN Laboratories Private Limited et al
as 1:2021cv01064
Counter Defendant: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant: MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Hetero Labs Limited et al
as 1:2021cv01063
Plaintiff: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant: Hetero Labs Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01062
Plaintiff: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: Patent Infringement
Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al
as 1:2021cv01067
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.
Cause Of Action: Patent Infringement
Allergan USA, Inc. et al v. Sun Pharmaceutical Industries Limited
as 1:2021cv01065
Plaintiff: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant: Sun Pharmaceutical Industries Limited
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Zydus Pharmaceuticals (USA) Inc.
as 1:2021cv01066
Plaintiff: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant: Zydus Pharmaceuticals (USA) Inc.
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Alkem Laboratories Limited
as 1:2021cv01061
Counter Defendant: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant: Alkem Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
MERZ PHARMACEUTICALS, LLC et al v. MSN PHARMACEUTICALS INC.
as 2:2021cv13731
Plaintiff: MERZ PHARMACEUTICALS, LLC and MERZ NORTH AMERICA, INC.
Defendant: MSN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01042
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: Patent Infringement
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01043
Plaintiff: Neurocrine Biosciences, Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?